Cardio Inc., a campus-based biotechnology corporation, is focused on the discovery, development, and commercialization of novel therapeutics -regenerative medicine and tissue engineering- that provide definitive and curative therapy for cardio-vascular disorders.
Our multifaceted research efforts encompass cell therapies, gene therapies, tissue engineering, and various interventional devices for regenerative medicine.
